Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novartis AG (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVS
New York
2834
https://www.novartis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novartis AG (ADR)
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
- Apr 24th, 2024 2:30 pm
Company News for Apr 24, 2024
- Apr 24th, 2024 1:36 pm
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
- Apr 24th, 2024 4:30 am
Why Novartis Stock Topped the Market on Tuesday
- Apr 23rd, 2024 10:25 pm
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
- Apr 23rd, 2024 9:05 pm
How Novartis Rode Two Blockbuster Drugs To Its Beat And Raise, And Three-Day Sprint
- Apr 23rd, 2024 8:01 pm
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
- Apr 23rd, 2024 5:42 pm
Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock
- Apr 23rd, 2024 4:24 pm
Novartis Stock Jumps After Beating Expectations, Raising Guidance
- Apr 23rd, 2024 3:32 pm
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
- Apr 23rd, 2024 3:15 pm
Novartis raises full-year guidance on Q1 beat, drug sales
- Apr 23rd, 2024 2:51 pm
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
- Apr 23rd, 2024 1:44 pm
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics
- Apr 23rd, 2024 1:30 pm
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
- Apr 23rd, 2024 1:00 pm
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and Schlumberger
- Apr 23rd, 2024 12:57 pm
Former Bristol Myers CEO tapped as Novartis’ next board chair
- Apr 23rd, 2024 12:02 pm
Novartis raises forecasts as top drug sales beat Wall Street estimates
- Apr 23rd, 2024 11:45 am
Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports
- Apr 23rd, 2024 9:12 am
UPDATE 1-Healthcare, tech stocks boost STOXX 600 to one-week high
- Apr 23rd, 2024 8:58 am
Novartis Raises Guidance on Profit, Sales Growth
- Apr 23rd, 2024 8:08 am
Scroll